Lineage Cell Therapeutics, Inc. (LCTX)

1.225 +0.02 (+1.24%) USD  |  NYAM  |  Jun 09, 16:00
1.225 0.00 (0.00%) After-Hours: 20:00
More

Lineage Cell Therapeutics Asset Utilization (TTM)

Asset Utilization (TTM) Chart

View Asset Utilization (TTM) for LCTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Asset Utilization (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Asset Utilization Definition

View Asset Utilization Definition
Start Trial

The asset utilization ratio calculates the total revenue earned for every dollar of assets a company owns.

Read full definition.

Asset Utilization (TTM) Range, Past 5 Years

View Asset Utilization (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Asset Utilization (TTM) Benchmarks

View Asset Utilization (TTM) Benchmarks
Start Trial
Curis, Inc. Upgrade
Halozyme Therapeutics, Inc. Upgrade
Agenus, Inc. Upgrade
Amgen, Inc. Upgrade
BioCryst Pharmaceuticals, Inc. Upgrade